ATyr Pharma Raises $76M Round to Advance Physocrine Drugs

BIOCON, 2015.04.03, BioMedia, News, pharma, physocrine, raises, round, 바이오, 0

ARS 전문 바이오벤쳐기업 ATyr Pharma가 7천 6백만 달러 (약 800억원)의 투자유치에 성공했다는 소식입니다. 첨부한 PDF 파일을 참조하시기 바랍니다.

0 Comments

Leave a reply Click here to cancel the reply

You must be logged in to post a comment.

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

©2010-2024 Medicinal Bioconvergence Research Center. All rights reserved.